radioligand - Robuta Search

https://rlt-angels.com/ RLT Angels – Enabling One Million Patients to Access Radioligand Therapy and Imaging - RLT-Angels RLT Angels – Enabling One Million Patients to Access Radioligand Therapy and Imaging https://portal.fis.tum.de/en/publications/psma-pet-tumor-to-salivary-gland-ratio-to-predict-response-to-sup/ PSMA PET Tumor-to-Salivary Gland Ratio to Predict Response to [177Lu]PSMA Radioligand Therapy: An... https://pmc.ncbi.nlm.nih.gov/articles/PMC7188707/ Realising the potential of radioligand therapy: policy solutions for the barriers to implementation... the potential radioligand therapy https://theses.gla.ac.uk/75936/ Evaluation of a Novel Non-Competitive Antagonist as a Radioligand for the N-Methyl-D-Aspartate... https://pubchem.ncbi.nlm.nih.gov/bioassay/1797989 AID 1797989 - ER-alpha Radioligand Binding Assay and ERE-Luciferase Reporter Assay. from Article... BioAssay record AID 1797989 submitted by BindingDB: ER-alpha Radioligand Binding Assay and ERE-Luciferase Reporter Assay. from Article 10.1021/jm030086h: https://pubchem.ncbi.nlm.nih.gov/bioassay/1794661 AID 1794661 - Angiotensin AT1 Eurofins-Panlabs radioligand binding assay - PubChem BioAssay record AID 1794661 submitted by ChEMBL: Angiotensin AT1 Eurofins-Panlabs radioligand binding assay. aid angiotensin eurofins radioligand binding https://www.novartis.com/research-and-development/technology-platforms/radioligand-therapy Radioligand Therapy | Novartis By harnessing the power of radioactive atoms and applying it to advanced cancers through radioligand therapy, RLTs are able to deliver radiation to target... radioligand therapy novartis https://www.techtransfer.nih.gov/patent/e-168-2017-0-us-01 RADIOLIGAND FOR ASSESSING HUMAN TRPV1 STRUCTURE-ACTIVITY RELATIONSHIPS AND METHOD OF USE |... https://pubchem.ncbi.nlm.nih.gov/bioassay/2060650 AID 2060650 - Radioligand Binding Assay from US Patent US20240398781: "SPIROCYCLIC CYCLIC... BioAssay record AID 2060650 submitted by BindingDB: Radioligand Binding Assay from US Patent US20240398781: from us aid radioligand binding assay https://pubchem.ncbi.nlm.nih.gov/bioassay/1801021 AID 1801021 - Radioligand Dose-Displacement Binding Assay from US Patent US8987287: "Spirocyclic... BioAssay record AID 1801021 submitted by BindingDB: Radioligand Dose-Displacement Binding Assay from US Patent US8987287: https://pubchem.ncbi.nlm.nih.gov/bioassay/1794706 AID 1794706 - Platelet Activating Factor (PAF) Eurofins-Panlabs radioligand binding assay - PubChem BioAssay record AID 1794706 submitted by ChEMBL: Platelet Activating Factor (PAF) Eurofins-Panlabs radioligand binding assay. https://pubchem.ncbi.nlm.nih.gov/bioassay/1804812 AID 1804812 - Radioligand Binding Assay from US Patent US10781171: "Substituted pyrrolidines as... BioAssay record AID 1804812 submitted by BindingDB: Radioligand Binding Assay from US Patent US10781171: from us https://adisinsight.springer.com/trials/700324133?error=cookies_not_supported&code=06d0bb0f-5db4-492e-b227-266180292bd8 Lutetium-177-PSMA-617 Radioligand Therapy in Oligo-metastatic Hormone Sensitive Prostate Cancer. -... This phase II study will evaluate the effect of 177Lu-PSMA in patients with hormone sensitive oligo-metastatic prostate cancer. https://pubchem.ncbi.nlm.nih.gov/bioassay/625257 AID 625257 - DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1) - PubChem BioAssay record AID 625257 submitted by ChEMBL: DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1). aid eta https://pubchem.ncbi.nlm.nih.gov/bioassay/1796248 AID 1796248 - Radioligand Binding Assay from US Patent US9656975: "Bicyclo[3.2.1]octyl amide... BioAssay record AID 1796248 submitted by BindingDB: Radioligand Binding Assay from US Patent US9656975: https://www.knowrlt.com/ Know RLT | Radioligand Therapies Novartis pioneered radioligand therapy by developing the first FDA-approved RLT. Learn more about the science of RLTs and how Novartis is reimaging cancer care. know rlt radioligand therapies https://pubchem.ncbi.nlm.nih.gov/bioassay/1806176 AID 1806176 - Human Orexin 1 Receptor Radioligand Binding Studies from US Patent USRE48841:... BioAssay record AID 1806176 submitted by BindingDB: Human Orexin 1 Receptor Radioligand Binding Studies from US Patent USRE48841: https://pubchem.ncbi.nlm.nih.gov/bioassay/145949 AID 145949 - Compound was tested for inhibition of [125I]eledoisin radioligand binding to NK3... BioAssay record AID 145949 submitted by ChEMBL: Compound was tested for inhibition of [125I]eledoisin radioligand binding to NK3 receptor from gerbil cortex;... https://pubchem.ncbi.nlm.nih.gov/bioassay/1801041 AID 1801041 - Radioligand Binding Assays from Article 10.1016/j.bioorg.2015.02.005: "The adenosine... BioAssay record AID 1801041 submitted by BindingDB: Radioligand Binding Assays from Article 10.1016/j.bioorg.2015.02.005: https://pubchem.ncbi.nlm.nih.gov/bioassay/625252 AID 625252 - DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) - PubChem BioAssay record AID 625252 submitted by ChEMBL: DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390). https://pubchem.ncbi.nlm.nih.gov/bioassay/157909 AID 157909 - Compound was tested for it''s ability to inhibit binding of [3H]LTD4, radioligand to... BioAssay record AID 157909 submitted by ChEMBL: Compound was tested for it''s ability to inhibit binding of [3H]LTD4, radioligand to its receptor at a... https://pubchem.ncbi.nlm.nih.gov/bioassay/145124 AID 145124 - Compound was tested for the inhibition of [3H]L-Glutamate radioligand binding to NMDA... BioAssay record AID 145124 submitted by ChEMBL: Compound was tested for the inhibition of [3H]L-Glutamate radioligand binding to NMDA receptor in synaptic... https://pubchem.ncbi.nlm.nih.gov/bioassay/1798593 AID 1798593 - Radioligand Binding Assay from Article 10.1016/j.bmc.2008.08.072: "A study of the... BioAssay record AID 1798593 submitted by BindingDB: Radioligand Binding Assay from Article 10.1016/j.bmc.2008.08.072: https://pubchem.ncbi.nlm.nih.gov/bioassay/1794673 AID 1794673 - Galanin GAL1 Eurofins-Panlabs radioligand binding assay - PubChem BioAssay record AID 1794673 submitted by ChEMBL: Galanin GAL1 Eurofins-Panlabs radioligand binding assay. aid eurofins radioligand binding assay https://pubchem.ncbi.nlm.nih.gov/bioassay/1803102 AID 1803102 - Radioligand dose-Displacement Binding Assay from US Patent US9388162: "Substituted... BioAssay record AID 1803102 submitted by BindingDB: Radioligand dose-Displacement Binding Assay from US Patent US9388162: https://digitalcommons.wustl.edu/oa_4/5638/ "Case report: Peptide receptor radioligand therapy in metastatic pediat" by Khanyisile Hlongwa,... Neuroendocrine tumors (NETs) are not commonly diagnosed in children. Metastatic NETs tend to have poor outcomes, and this is seen in adult and pediatric... case report radioligand therapy https://pubmed.ncbi.nlm.nih.gov/40697966/ Advanced Image Analysis to Select Patients for Prostate Specific Membrane Antigen Radioligand... Advanced Image Analysis to Select Patients for Prostate Specific Membrane Antigen Radioligand Therapy and Assess Treatment Response advanced image https://experts.arizona.edu/en/publications/sup125supisnf-8702-a-selective-radioligand-for-ccksubbsub-recepto/ [125I]SNF 8702: A selective radioligand for CCKB receptors - University of Arizona https://www.techtransfer.nih.gov/tech/tab-3686 Radioligand for imaging brain PDE4 subtype D receptors with positron emission tomography |... https://marianaoncology.com/ Pioneering Novel Radioligand Therapeutics | Mariana Oncology Mariana Oncology, a Novartis company, is advancing precision radioligand therapies designed to optimize efficacy while allowing patients to live better during... pioneering novel radioligand therapeutics mariana https://pubchem.ncbi.nlm.nih.gov/bioassay/1804827 AID 1804827 - Radioligand Displacement Assay from US Patent US10787419: "Cannabinoid receptor... BioAssay record AID 1804827 submitted by BindingDB: Radioligand Displacement Assay from US Patent US10787419: from us aid radioligand displacement assay https://pubmed.ncbi.nlm.nih.gov/28815446/ A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors human pet https://pubmed.ncbi.nlm.nih.gov/2723659/ A kinetic analysis of kappa-opioid agonist binding using the selective radioligand [3H]U69593 The interaction of the nonselective opioid ligand [3H]bremazocine and of the kappa-opioid [3H]U69593 with the kappa-receptor was investigated in guinea-pig... https://adisinsight.springer.com/drugs/800086982?error=cookies_not_supported&code=a75a83fa-788d-43cb-850d-58dac81e66a6 Research programme: radioligand-antibody conjugates - Klasther Biopharma - AdisInsight Radioligand-antibody conjugates directed against tumor-specific post-translational modifications (PTMs) are being developed by Klasther Biopharma (spin-off from research programme antibody conjugates radioligand biopharma adisinsight https://pubchem.ncbi.nlm.nih.gov/bioassay/1801375 AID 1801375 - Radioligand Binding Assay from US Patent US9067949: "Benzofuro[3,2-c] pyridines and... BioAssay record AID 1801375 submitted by BindingDB: Radioligand Binding Assay from US Patent US9067949: https://theses.gla.ac.uk/41126/ Cellular distribution of alpha1-adrenoceptors using visualisation and radioligand binding... cellular distribution using visualisation radioligand https://pubmed.ncbi.nlm.nih.gov/38555542/ Advances in Radioligand Theranostics in Oncology Theranostics with radioligands (radiotheranostics) has played a pivotal role in oncology. Radiotheranostics explores the molecular targets expressed on tumor... advances radioligand theranostics oncology https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0238393&fbclid=IwAR2KYVZlMbueHiHbSG6iy11_WVbSwwLcEovtW33giBsTzZIfoOxxiDFIDxU A radioligand binding assay for the insulin-like growth factor 2 receptor | PLOS One Insulin-like growth factors 2 and 1 (IGF2 and IGF1) and insulin are closely related hormones that are responsible for the regulation of metabolic homeostasis,... https://pubchem.ncbi.nlm.nih.gov/bioassay/1801797 AID 1801797 - Radioligand Binding Assay from US Patent US9173879: "Crystalline forms of... BioAssay record AID 1801797 submitted by BindingDB: Radioligand Binding Assay from US Patent US9173879: from us https://portal.fis.tum.de/en/publications/from-netter-to-petter-psma-targeted-radioligand-therapy/ From NETTER to PETTER: PSMA-Targeted radioligand therapy - Technical University of Munich https://pubchem.ncbi.nlm.nih.gov/bioassay/1804723 AID 1804723 - Competition Radioligand Binding Assay from US Patent US10744125: "Adenosine A3... BioAssay record AID 1804723 submitted by BindingDB: Competition Radioligand Binding Assay from US Patent US10744125: https://pubchem.ncbi.nlm.nih.gov/bioassay/1963493 AID 1963493 - Measurement of A2A or A2B Binding Affinity Using Radioligand Binding from US Patent... BioAssay record AID 1963493 submitted by BindingDB: Measurement of A2A or A2B Binding Affinity Using Radioligand Binding from US Patent US20240076297: https://pubchem.ncbi.nlm.nih.gov/bioassay/1801799 AID 1801799 - Radioligand Binding Assay from US Patent US9173879: "Crystalline forms of... BioAssay record AID 1801799 submitted by BindingDB: Radioligand Binding Assay from US Patent US9173879: from us https://pubchem.ncbi.nlm.nih.gov/bioassay/1796828 AID 1796828 - Radioligand Binding Assay on Rat from US Patent US9663530:... BioAssay record AID 1796828 submitted by BindingDB: Radioligand Binding Assay on Rat from US Patent US9663530: from us aid radioligand binding assay https://collaborate.princeton.edu/en/publications/r-25-dimethoxy-4-sup77supbromoamphetamine-sup77supbr-r-dob-a-nove/ R(-)-2,5-Dimethoxy-4-77bromoamphetamine [77Br-R(-)DOB]: a novel radioligand which labels a 5-HT... https://pubchem.ncbi.nlm.nih.gov/bioassay/1794636 AID 1794636 - Thyrotropin Releasing Hormone (TRH) Eurofins-Panlabs radioligand binding assay -... BioAssay record AID 1794636 submitted by ChEMBL: Thyrotropin Releasing Hormone (TRH) Eurofins-Panlabs radioligand binding assay. aid releasing hormone https://pubchem.ncbi.nlm.nih.gov/bioassay/1795659 AID 1795659 - Radioligand Binding Assay on Rat TAAR1 from US Patent US10023559: "Substituted... BioAssay record AID 1795659 submitted by BindingDB: Radioligand Binding Assay on Rat TAAR1 from US Patent US10023559: https://pubchem.ncbi.nlm.nih.gov/bioassay/1794696 AID 1794696 - Vasopressin V2 Eurofins-Panlabs radioligand binding assay - PubChem BioAssay record AID 1794696 submitted by ChEMBL: Vasopressin V2 Eurofins-Panlabs radioligand binding assay. aid vasopressin eurofins radioligand binding https://pubchem.ncbi.nlm.nih.gov/bioassay/1797586 AID 1797586 - Radioligand Binding Assay from US Patent US9809582: "Aminoester derivatives" - PubChem BioAssay record AID 1797586 submitted by BindingDB: Radioligand Binding Assay from US Patent US9809582: from us https://pubchem.ncbi.nlm.nih.gov/bioassay/1801244 AID 1801244 - Radioligand Binding Assay from US Patent US9034899: "Aryl, heteroaryl, and... BioAssay record AID 1801244 submitted by BindingDB: Radioligand Binding Assay from US Patent US9034899: from us https://pubchem.ncbi.nlm.nih.gov/bioassay/625190 AID 625190 - DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H]... BioAssay record AID 625190 submitted by ChEMBL: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT). aid serotonin https://pharma.economictimes.indiatimes.com/news/pharma-industry/novartis-to-set-up-new-radioligand-therapy-facility-in-florida-under-23-bn-us-mfg-push/126435904 Novartis Invests in Radioligand Therapy in Florida Amid $23 Billion US Manufacturing Expansion,... Novartis is setting up a new radioligand therapy manufacturing facility in Winter Park, Florida, as part of its $23 billion investment in US manufacturing... radioligand therapy https://pubchem.ncbi.nlm.nih.gov/bioassay/1806355 AID 1806355 - In-Vitro Radioligand Binding Assasy from US Patent US11253514: "Triple combination of... BioAssay record AID 1806355 submitted by BindingDB: In-Vitro Radioligand Binding Assasy from US Patent US11253514: https://pubchem.ncbi.nlm.nih.gov/bioassay/147679 AID 147679 - Inhibition by the compound against [125I]BH-SP radioligand binding to neurokinin-1... BioAssay record AID 147679 submitted by ChEMBL: Inhibition by the compound against [125I]BH-SP radioligand binding to neurokinin-1 (NK-1) receptor in human...